C669-2607 Screening compound: N-{3-[(2H-1,3-benzodioxol-5-yl)amino]quinoxalin-2-yl}-4-chlorobenzene-1-sulfonamide

C669-2607 Screening compound: N-{3-[(2H-1,3-benzodioxol-5-yl)amino]quinoxalin-2-yl}-4-chlorobenzene-1-sulfonamide
C669-2607 Screening compound: N-{3-[(2H-1,3-benzodioxol-5-yl)amino]quinoxalin-2-yl}-4-chlorobenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C669-2607
N-{3-[(2H-1,3-benzodioxol-5-yl)amino]quinoxalin-2-yl}-4-chlorobenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C669-2607

Molecular Formula

C21H15ClN4O4S (C21 H15 ClN4 O4 S)

Compound Name

N-{3-[(2H-1,3-benzodioxol-5-yl)amino]quinoxalin-2-yl}-4-chlorobenzene-1-sulfonamide

IUPAC name

N-{3-[(2H-13-benzodioxol-5-yl)amino]quinoxalin-2-yl}-4-chlorobenzene-1-sulfonamide

SMILES

O=S(c(cc1)ccc1Cl)(Nc1nc2ccccc2nc1Nc(cc1)cc2c1OCO2)=O

InChI

InChI=1S/C21H15ClN4O4S/c22-13-5-8-15(9-6-13)31(27,28)26-21-20(24-16-3-1-2-4-17(16)25-21)23-14-7-10-18-19(11-14)30-12-29-18/h1-11H,12H2,(H,23,24)(H,25,26)

InChI Key

GCSOBEMCAFWNFC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01563223

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.89

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.994

Distribution Coefficient, logD

3.448

Water Solubility, LogSw

-5.16

Polar Surface Area

85.128

Acid Dissociation Constant (pKa)

5.87

Base Dissociation Constant (pKb)

3.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.80

C669-2607 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

C-Met Library (15277 compounds)

New Agro Library (44492 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
Agro:
  • Agro

References: we are preparing a list of scientific research reports with C669-2607 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C669-2607?
Check Price and Availability of C669-2607, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C669-2607 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C669-2607
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C669-2607
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C669-2607 available by request